Shareholders might have noticed that Cencora, Inc. (NYSE:COR) filed its quarterly result this time last week. The early response was not positive, with shares down 3.1% to US$283 in the past week.

Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $250 billion in annual US healthcare distribution sales, the firm ...

CONSHOHOCKEN, Pa. (AP) — CONSHOHOCKEN, Pa. (AP) — Cencora, Inc. (COR) on Wednesday reported fiscal second-quarter profit of $717.9 million. On a per-share basis, the Conshohocken, Pennsylvania ...

Healthcare distributor Cencora (NYSE:COR) will be reporting earnings tomorrow before the bell. Here’s what to expect. Cencora beat analysts’ revenue expectations by 5.2% last quarter ...

Alto and Cencora are collaborating to deliver enhanced patient support services and streamline access to prescribed specialty medications. The collaboration leverages Cencora’s patient support ...

Walgreens Boots settles prepaid share contracts early, generating $300M in proceeds. WBA reduces Cencora stake from 10% to 6% to support debt reduction. Unlock your all-in-one trading dashboard ...

Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...

Cencora has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale ...

Cencora Inc (NYSE:COR), a prominent player in the Healthcare Providers & Services industry with a market capitalization of $45.7 billion, has been navigating a complex market landscape ...

Cencora, Inc. COR recently completed the previously announced acquisition of Retina Consultants of America (“RCA”), a leading management services organization (“MSO”) of retina specialists ...

Please provide your email address to receive an email when new articles are posted on . Cencora completed its acquisition of Retina Consultants of America, according to a press release.